Eagle Capital Management (New York)
MRK icon

Eagle Capital Management (New York)’s Merck MRK Stock Holding History

Eagle Capital Management (New York)’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,595
Closed -$435K – 55
2021
Q2 		$435K Buy
+5,595
New +$416K ﹤0.01% 52

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Eagle Capital Management (New York)'s MRK Position: Q3 2021 in Review

Eagle Capital Management (New York) sold out of Merck (MRK) in Q3 2021, closing a stake of 5,595 shares — an estimated $435K sold.

Eagle Capital Management (New York) first reported a position in MRK in Q2 2021 and held it in 1 quarter. The position peaked at $435K in Q2 2021. 2,648 funds tracked by Wall St. Rank hold MRK as of Q3 2021.

  • Eagle Capital Management (New York) reported no remaining Merck position as of Q3 2021 after selling out during the quarter.
  • Eagle Capital Management (New York) sold 5,595 Merck shares in Q3 2021, an estimated $435K.
  • Eagle Capital Management (New York) first reported a position in Merck in Q2 2021 and held it in 1 quarter.
  • Eagle Capital Management (New York)'s Merck position peaked at $435K in Q2 2021.
  • 2,648 funds tracked by Wall St. Rank held Merck as of Q3 2021.

Based on Eagle Capital Management (New York)'s 13F filing for Q3 2021, filed 15 Nov 2021.